Zobrazeno 1 - 10
of 360
pro vyhledávání: '"D A. Sychev"'
Autor:
l. V. Fedina, i. N. Sychev, K. V. Mirzaev, A. V. Vardanyan, S. V. Glagolev, A. A. Kachanova, P. O. Bochkov, R. V. Shevchenko, S. N. Tuchkova, I. V. Sychev, S. P. Abdullaev, D A. Sychev
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 20, Iss 1, Pp 19-26 (2024)
Aim. The aim of our study was to investigate the influence of polymorphic markers of CYP3A4*22 CYP3A4*22 (c.522-191C>T, rs35599367), CYP3A5*3 (c.219237A>G, rs776746), ABCB1 rs1045642 (c.3435T>C) and rs4148738 (c.2692-2236C>T) genes on the plasma conc
Externí odkaz:
https://doaj.org/article/895693a579cb4ad08184d9190f32a514
Autor:
A. I. Parusov, I. D. Loranskaya, K. A. Akmalova, Zh. A. Sozaeva, O. L. Turkina, M. S. Zastrozhin, D. A. Sychev
Publikováno v:
Медицинский совет, Vol 0, Iss 6, Pp 83-91 (2022)
Introduction. Despite the huge number of modern recommendations for the treatment of patients with liver cirrhosis, there is still no clear scheme for prescribing non-selective beta-blockers.Aim. To evaluate effect of polymorphic markers CYP2D6*3, CY
Externí odkaz:
https://doaj.org/article/3b82df48d7ed4d4b9ef9dc3b87929b9e
Publikováno v:
Медицинский совет, Vol 0, Iss 21-2, Pp 35-43 (2022)
Introduction. A treatment for LFR for many years, the superiority of PPIs over placebos is still controversial. Of particular clinical importance is the metabolic rate of PPIs in hepatocytes using the cytochrome P450 system with the participation of
Externí odkaz:
https://doaj.org/article/b216028bd63849f9a8d302e69952f466
Autor:
I. N. Sychev, L. V. Fedina, A. S. Osipov, I. I. Temirbulatov, O. Yu. Tataroy, Zh. A. Sozaeva, K. A. Akmalova, N. P. Denisenko, S. P. Abdullaev, A. A. Kachanova, E. A. Grishina, K. B. Mirzaev, D. A. Sychev
Publikováno v:
Медицинский совет, Vol 0, Iss 4, Pp 41-46 (2021)
Introduction. Apixaban is a direct oral anticoagulant prescribed for treatment and prevention of venous thromboembolism (VTE) and for prevention of stroke in patients with nonvalvular atrial fibrillation. Direct oral anticoagulants (DOACs) such as ap
Externí odkaz:
https://doaj.org/article/5ad7ad0be6504c7ca0446a126b130503
Autor:
N. M. Krasnova, E. N. Efremova, A. A. Egorova, O. I. Filippova, Y. V. Chertovskikh, Z. A. Rudykh, E. A. Alekseeva, T. E. Tatarinova, D. A. Sokorutov, N. S. Val, M. K. Vinokurova, A. F. Karvchenko, A. I. Vengerovskii, D. A. Sychev
Publikováno v:
Бюллетень сибирской медицины, Vol 19, Iss 4, Pp 102-109 (2021)
Aim. To assess the variability of the NAT2 gene and to comparatively analyze the prevalence of NAT2 polymorphisms and acetylation types among Yakut and Russian patients newly diagnosed with pulmonary tuberculosis (TB), permanently residing in the Sak
Externí odkaz:
https://doaj.org/article/4c8b069261034b5fbc7832841e2d1fde
Autor:
M. S. Zastrozhin, E. A. Grishina, K. A. Ryzhikova, V. Yu. Skryabin, S. G. Koporov, E. A. Bryun, D. A. Sychev
Publikováno v:
Бюллетень сибирской медицины, Vol 19, Iss 4, Pp 73-79 (2021)
Background. Mirtazapine is used to treat patients with depressive disorders. A large proportion of patients in this group do not adequately respond to mirtazapine therapy, while many develop undesirable drug reactions of type A. According to the prev
Externí odkaz:
https://doaj.org/article/5dca72f9a4594efe8a4895f8c5943d7d
Autor:
N. A. Chernikova, L. L. Kamynina, A. S. Ametov, D. A. Sychev, E. A. Grishina, K. A. Ryzhikova
Publikováno v:
Терапевтический архив, Vol 92, Iss 10, Pp 54-62 (2020)
Aim.To investigate the link between the hypoglycemia (registrated accurately by the professional Continuous Glucose Monitoring CGM; severe hypoglycemia at home) and the hetero-/homozygote carriage of single nucleotide polymorphisms (SNP) of cytochrom
Externí odkaz:
https://doaj.org/article/06dad1e45df24ff5ba09f393f973032b
Autor:
K. B. Mirzaev, D. S. Fedorinov, K. A. Akmalova, Sh. P. Abdullaev, A. A. Kachanova, Zh. A. Sozaeva, E. A. Grishina, G. N. Shuev, E. Yu. Kitaeva, V. V. Shprakh, S. Sh. Suleymanov, L. Z. Bolieva, M. S-H. Sozaeva, S. M. Zhuchkova, N. E. Gimaldinova, E. E. Sidukova, I. S. Burashnikova, A. A. Shikaleva, K. G. Zabudskaya, D. A. Sychev
Publikováno v:
Терапевтический архив, Vol 92, Iss 8, Pp 43-51 (2020)
Aim. To study the peculiarities of carrying clinically significant allelic variants of TPMT and DPYD genes associated with the response to drug therapy in cancer practice among 9 ethnic groups of the Russian Federation. Materials and methods. The
Externí odkaz:
https://doaj.org/article/2f106cc4a30443afab05a69a71feda97
Autor:
A. A. Chernov, E. B. Kleymenova, D. A. Sychev, L. P. Yashina, M. D. Nigmatkulova, V. A. Otdelenov, S. A. Payushchik
Publikováno v:
Терапевтический архив, Vol 92, Iss 8, Pp 37-42 (2020)
Background. In 819% of patients with atrial fibrillation (AF) with anticoagulant therapy (ACT), hemorrhagic complications occur, including due to excess doses of AC. At the same time, ACT is necessary for patients with AF, since anticoagulants effect
Externí odkaz:
https://doaj.org/article/523a80d97dca4532b7f0ef28ce6dae17
Autor:
I. V. Poddubnaya, D. A. Sychev, G. R. Abuzarova, A. K. Allakhverdiev, P. P. Arkhiri, L. G. Babicheva, M. P. Baranova, M. I. Volkova, A. V. Ignatova, A. Iu. Kashurnikov, R. I. Kniazev, I. V. Kolyadina, I. G. Komarov, A. V. Kriukov, N. V. Levitskaia, V. K. Liadov, O. A. Malikhova, S. N. Nered, N. F. Orel, S. O. Podviaznikov, I. V. Sagaidak, R. R. Sarmanaeva, I. S. Stilidi, O. P. Trofimova, G. S. Tumian, T. V. Kharitonova
Publikováno v:
Современная онкология, Vol 22, Iss 2, Pp 56-73 (2020)
The training module was developed by the staff of the department under the leadership of the head. Department of Academician of RAS, Professor I.V. Poddubnoy and Rector of FSBEI DPO RMANPO of the Ministry of Health of Russia, Corr. RAS, Professor D.A
Externí odkaz:
https://doaj.org/article/828b754feb9b44bfa87fb7395a012d1c